Molecular Aspects of Chemotherapy

Molecular dynamics simulations have been performed on two penicillin-recognizing proteins. One protein is an enzyme from Streptomyces R61 and has transpeptidase and carboxypeptidase activity on peptide substrates terminating in D-alanyl-D-alanine. The DD-peptidase is a model for penicillin-binding proteins (PBPs) controlling bacterial peptidoglycan biosynthesis and is inhibited by various classes of natural and synthetic f3-lactam antibiotics. The second protein is a f3-lactamase from Bacillus licheniformis 749/C and deactivates penicillins and other f3-lactam antibiotics by hydrolyzing them to inactive products. Crystallographic data for the two proteins have been refined by molecular mechanics energy mini-' mizations, and the conformation space available to the proteins immersed in an 8-A layer of water molecules has been explored by molecular dynamics simulations. The solid state model of the DD-peptidase is found to be much further from an energy-optimized structure than in the case of the f3-lactamase. The DD-peptidase is discovered to have a flexible loop that can transiently close access to the active site serine. An overview of recent modeling studies of 13and y-Iactam antibiotics illustrate the type of information that can be obtained with modem methodologies of computational chemistry.

[1]  D. Helfman,et al.  A homogeneous cyclic CMP phosphodiesterase hydrolyzes both pyrimidine and purine cyclic 2':3'- and 3':5'-nucleotides. , 1982, The Journal of biological chemistry.

[2]  A Wlodawer,et al.  Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases. , 1991, Biochemistry.

[3]  Designing CD4 immunoadhesins for AIDS therapy. , 1990, Disease markers.

[4]  D. Shugar Progress with antiviral agents , 1974, FEBS letters.

[5]  Thomas P. J. Garrett,et al.  Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains , 1990, Nature.

[6]  F. Karst,et al.  Ertosterol biosynthesis in Saccharomyces cerevisiae: mutants deficient in the early steps of the pathway. , 1977, Molecular & general genetics : MGG.

[7]  J. Payne Oligopeptide transport in Escherichia coli. Specificity with respect to side chain and distinction from dipeptide transport. , 1968, The Journal of biological chemistry.

[8]  E. Borowski,et al.  Substrate specificity of peptide permeases in Candida albicans , 1988 .

[9]  T. Chou,et al.  Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine. , 1991, Molecular pharmacology.

[10]  N. Brown,et al.  Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases. , 1990, Pharmacology & therapeutics.

[11]  J. Dzik,et al.  Interaction of the 5'-phosphates of the anti-HIV agents, 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine, with thymidylate synthase. , 1988, Biochemical and biophysical research communications.

[12]  L. Tomaszewski [Peptide transport]. , 1976, Polski tygodnik lekarski.

[13]  D. Montefiori,et al.  Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors. , 1989, Antiviral research.

[14]  C. Higgins,et al.  Anaerobic and leucine-dependent expression of a peptide transport gene in Salmonella typhimurium , 1984, Journal of bacteriology.

[15]  E. De Clercq,et al.  Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. , 1987, Antiviral research.

[16]  D. R. Dubbs,et al.  Characterization of nucleoside phosphotransferase and thymidine kinase activities of chick embryo cells and of chick-mouse somatic cell hybrids. , 1975, Archives of biochemistry and biophysics.

[17]  I. H. Segel,et al.  Adenosine 5'-phosphosulfate kinase from Penicillium chrysogenum. Purification and kinetic characterization. , 1984, The Journal of biological chemistry.

[18]  T. Feizi,et al.  Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumour-associated antigens and components of receptor systems , 1985 .

[19]  D. Sandoli,et al.  Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases. , 1990, Journal of medicinal chemistry.

[20]  C. Hassall,et al.  Phosphonopeptides as Antibacterial Agents: Rationale, Chemistry, and Structure-Activity Relationships , 1979, Antimicrobial Agents and Chemotherapy.

[21]  T. Traut,et al.  Uridine kinase from Ehrlich ascites carcinoma. Purification and properties of homogeneous enzyme. , 1985, The Journal of biological chemistry.

[22]  A. Webster Cytomegalovirus as a possible cofactor in HIV disease progression. , 1991, Journal of acquired immune deficiency syndromes.

[23]  J. D. Karkas,et al.  Inhibition of human purine nucleoside phosphorylase by acyclic nucleosides and nucleotides. , 1987, Biochemical Pharmacology.

[24]  R. Siliciano,et al.  A soluble CD4 protein selectively inhibits HIV replication and syncytium formation , 1988, Nature.

[25]  A. Fridland,et al.  Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells. , 1989, Molecular pharmacology.

[26]  R. Lewis,et al.  Phosphorylation of arabinosyl guanine by a mitochondrial enzyme of bovine liver. , 1989, Biochemical pharmacology.

[27]  H. Mitsuya,et al.  Molecular targets for AIDS therapy. , 1990, Science.

[28]  D. Ives,et al.  Properties of a highly purified mitochondrial deoxyguanosine kinase. , 1988, Archives of biochemistry and biophysics.

[29]  E. De Clercq Specific targets for antiviral drugs. , 1982, The Biochemical journal.

[30]  E. De Clercq,et al.  Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T‐cell lymphotropic virus (HTLV‐III)/lymphadenopathy‐associated virus (LAV) , 1986, International journal of cancer.

[31]  G. F. Ames Bacterial periplasmic transport systems: structure, mechanism, and evolution. , 1986, Annual review of biochemistry.

[32]  A Wlodawer,et al.  Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. , 1991, Biochemistry.

[33]  C. Higgins,et al.  Peptide transport in bacteria. , 1986, Methods in enzymology.

[34]  Y. Satow,et al.  Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. , 1985, Journal of molecular biology.

[35]  M. Navia,et al.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.

[36]  W. Hendrickson Stereochemically restrained refinement of macromolecular structures. , 1985, Methods in enzymology.

[37]  R. Dewar,et al.  Biosynthesis andProcessing ofHumanImmunodeficiency Virus Type1Envelope Glycoproteins: Effects ofMonensin on Glycosylation andTransport , 1989 .

[38]  D. Sutton,et al.  Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture , 1987, Antimicrobial Agents and Chemotherapy.

[39]  R. Wolfenden,et al.  Inhibition of thymidine kinase by P1-(adenosine-5')-P5-(thymidine-5')-pentaphosphate. , 1986, The Journal of biological chemistry.

[40]  J. Glorioso,et al.  Demonstration and mapping of highly carbohydrate-dependent epitopes in the herpes simplex virus type 1-specified glycoprotein C. , 1987, The Journal of general virology.

[41]  E. Borowski,et al.  Synthesis and biological properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid dipeptides, a novel group of antimicrobial agents. , 1987, Journal of medicinal chemistry.

[42]  R. L. Jarvest,et al.  Synthesis and antiviral activity of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purines. , 1987, Journal of medicinal chemistry.

[43]  F. Viola,et al.  Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives , 1987 .

[44]  C. Miller,et al.  Reversible repression and activation of measles virus infection in neural cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[45]  John P. Overington,et al.  X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes , 1989, Nature.

[46]  K. M. Hwang,et al.  Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. , 1988, Science.

[47]  S. Marsters,et al.  Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. , 1987, Science.

[48]  E. De Clercq,et al.  Inhibition of terminal N- and O-glycosylation specific for herpesvirus-infected cells: mechanism of an inhibitor of sugar nucleotide transport across Golgi membranes. , 1988, Virology.

[49]  J. Gleaves,et al.  The role of outer membrane proteins in peptide uptake by Escherichia coli , 1985 .

[50]  M. R. Harnden Development of 9-(4-hydroxy-3-(hydroxymethyl)but-1-yl)purines as potential therapeutic agents for treatment of human herpes virus infections , 1989 .

[51]  R. Hanzlik,et al.  [9] Synthesis of labeled squalene and squalene 2,3-oxide , 1969 .

[52]  F. Viola,et al.  Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase , 1988 .

[53]  C. Gilvarg,et al.  Transport of impermeant substances in E. coli by way of oligopeptide permease. , 1973, Nature: New biology.

[54]  R. Kunze,et al.  Influence of sulfated carbohydrates on the accessibility of CD4 and other CD molecules on the cell surface and implications for human immunodeficiency virus infection , 1989, European journal of immunology.

[55]  R. Freidinger,et al.  Non-peptide ligands for peptide receptors. , 1989, Trends in pharmacological sciences.

[56]  J. Groopman,et al.  Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4 , 1989, Journal of virology.

[57]  R. L. Jarvest,et al.  An improved synthesis of the antiviral acyclonucleoside 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine , 1985 .

[58]  J. D. Karkas,et al.  Synthetic, Biochemical and Antiviral Aspects of Selected Acyclonucleosides and Their Derivatives. , 1986 .

[59]  G. Richarme,et al.  Study of binding protein-ligand interaction by ammonium sulfate-assisted adsorption on cellulose esters filters. , 1983, Biochimica et biophysica acta.

[60]  J. Harb,et al.  Purification of bovine liver cytosolic 5'-nucleotidase. Kinetic and structural studies as compared to the membrane isoenzyme. , 1988, European journal of biochemistry.

[61]  E. Egyházi,et al.  5,6‐dichlororibofuranosylbenzimidazole (DRB) is phosphorylated in salivary gland cells of Chironomus tentans , 1979, FEBS letters.

[62]  A. Sjoerdsma,et al.  ANTI-HIV ACTIVITY OF CASTANOSPERMINE ANALOGUES , 1989, The Lancet.

[63]  J. Payne,et al.  Limitations to the use of radioactively labelled substrates for studying peptide transport in microorganisms , 1980, FEBS letters.

[64]  S. Lederman,et al.  Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. , 1989, Journal of immunology.

[65]  P. Reichard,et al.  Cytoplasmic 5'(3')-nucleotidase from human placenta. , 1990, The Journal of biological chemistry.

[66]  A. D. Broom Rational design of enzyme inhibitors: multisubstrate analogue inhibitors. , 1989, Journal of medicinal chemistry.

[67]  S. Ikeda,et al.  Multisubstrate Analogs for Deoxynucleoside Kinases , 1985 .

[68]  R. Miller,et al.  Guanosine kinase from Trichomonas vaginalis. , 1991, Molecular and biochemical parasitology.

[69]  E. De Clercq,et al.  Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight. , 1991, Journal of medicinal chemistry.

[70]  B. Walker,et al.  Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine , 1989, Antimicrobial Agents and Chemotherapy.

[71]  S. Miller,et al.  Cloning and characterization of the 2,3-oxidosqualene cyclase-coding gene of Candida albicans. , 1990, Gene.

[72]  C. Higgins,et al.  Uptake of cell wall peptides by Salmonella typhimurium and Escherichia coli , 1987, Journal of bacteriology.

[73]  S. Olofsson,et al.  Activity of herpes simplex virus type 1-specified glycoprotein C antigenic site II epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharides. , 1990, The Journal of general virology.

[74]  S. Olofsson,et al.  New Virus-Selective Inhibitor of Terminal Glycosylation Increasing Immunological Reactivity of a Viral Glycoprotein , 1990 .

[75]  B. Walker,et al.  Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[76]  R Itoh,et al.  Purification and some properties of cytosol 5'-nucleotidase from rat liver. , 1981, Biochimica et biophysica acta.

[77]  D. Huso,et al.  Sialic acids on the surface of caprine arthritis-encephalitis virus define the biological properties of the virus , 1988, Journal of virology.

[78]  R. Axel,et al.  soluble form of CD4 (T4) protein inhibits AIDS virus infection , 1988, Nature.

[79]  E. Egyházi,et al.  Kinetic analysis of uptake and phosphorylation of 5,6-dichlororibofuranosylbenzimidazole (DRB) by salivary gland cells of Chironomus tentans. , 1980, The Journal of biological chemistry.

[80]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[81]  D. Sutton,et al.  Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir] , 1989, Antimicrobial Agents and Chemotherapy.

[82]  I. Abe,et al.  Purification and some properties of squalene-2,3-epoxide: lanosterol cyclase from rat liver. , 1991, Chemical and pharmaceutical bulletin.

[83]  A Wlodawer,et al.  X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[84]  B. Walker,et al.  HIV infection is blocked in vitro by recombinant soluble CD4 , 1988, Nature.

[85]  D. Longo,et al.  Death in the AIDS patient: role of cytomegalovirus. , 1983, The New England journal of medicine.

[86]  The MHC-binding and gp120-binding functions of CD4 are separable. , 1990, Disease markers.

[87]  F. Schuber,et al.  Partial purification of 2,3-oxidosqualene-lanosterol cyclase from hog-liver. Evidence for a functional thiol residue. , 1988, Biochemical and biophysical research communications.

[88]  D. Earnshaw,et al.  Synthesis of isotopically chiral [13C]penciclovir (BRL 39123) and its use to determine the absolute configuration of penciclovir triphosphate formed in herpes virus infected cells , 1990 .

[89]  S. Broder,et al.  Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells. , 1988, The Journal of biological chemistry.

[90]  I. Pastan,et al.  Recombinant CD4-Pseudomonas exotoxin hybrid protein displays HIV-specific cytotoxicity without affecting MHC class II-dependent functions. , 1990, AIDS research and human retroviruses.

[91]  J. Payne Peptides and micro-organisms. , 1976, Advances in microbial physiology.

[92]  I. Weber,et al.  Comparison of inhibitor binding in HIV‐1 protease and in non‐viral aspartic proteases: the role of the flap , 1990, FEBS letters.

[93]  J. Morley,et al.  Antibacterial activity and uptake into Escherichia coli of backbone-modified analogues of small peptides. , 1983, Journal of general microbiology.

[94]  M. Jaskólski,et al.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.

[95]  H. Varmus,et al.  Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase , 1990, Journal of virology.

[96]  P. Volberding,et al.  Lack of response to suramin in patients with AIDS and AIDS-related complex. , 1987, The American journal of medicine.

[97]  J. Weinstein,et al.  Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[98]  S. Olofsson,et al.  The antiherpes drug (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdU) interferes with formation of N-linked and of O-linked oligosaccharides of the herpes simplex virus type 1 glycoprotein C. , 1985, Virology.

[99]  W. Lüke,et al.  Soluble CD4 molecules neutralize human immunodeficiency virus type 1 , 1988, Nature.

[100]  E. Clercq Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses , 1979 .

[101]  L. Larsson,et al.  A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis , 1987, Nature.

[102]  M. Smith,et al.  Simultaneous exploitation of different peptide permeases by combinations of synthetic peptide smugglins can lead to enhanced antibacterial activity. , 1990, FEMS microbiology letters.

[103]  R. Kerbel,et al.  Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. , 1987, Science.

[104]  R. Hodge,et al.  Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells , 1989, Antimicrobial Agents and Chemotherapy.

[105]  M. Simpson,et al.  Deoxyribonucleic acid biosynthesis in mitochondria. Purification and general properties of rat liver mitochondrial deoxyribonucleic acid polymerase. , 1970, The Journal of biological chemistry.

[106]  G. Ames,et al.  Bacterial periplasmic permeases belong to a family of transport proteins operating from Escherichia coli to human: Traffic ATPases. , 1990, FEMS microbiology reviews.

[107]  Y. Cheng,et al.  Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs. , 1987, The Journal of biological chemistry.

[108]  K. M. Hwang,et al.  CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[109]  L. Lasky,et al.  Model for intracellular folding of the human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.

[110]  J. Payne,et al.  Direct determination of the properties of peptide transport systems in Escherichia coli, using a fluorescent-labeling procedure , 1979, Journal of bacteriology.

[111]  D. Norbeck,et al.  Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. , 1990, Science.

[112]  S. Broder,et al.  Suppression of retroviral propagation and disease by suramin in murine systems. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[113]  J. C. Martin,et al.  In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analogues. , 1990, Journal of the National Cancer Institute.

[114]  E. E. Tamelen BIOORGANIC CHARACTERIZATION AND MECHANISM OF THE 2,3-OXIDOSQUALENE → LANOSTEROL CONVERSION , 1983 .